TAG:
laboratories
Failure of AD Pathlabs: Structural Weakness?
CEO SUMMARY: AD PathLabs is the latest in a string of business disappointments. Over the past decade, a number of anatomic pathology companies have proven that they can grow rapidly—attracting substantial volumes of specimens. But these companies seem to hit a financial wall that leads …
Luminex and PerkinElmer Ink Licensing Agreement
CEO SUMMARY: PerkinElmer’s interest in the multiplex capabilities of Luminex’s xMap technology led to this new licensing agreement. PerkinElmer’s instrument systems played a major role in accelerating the work of the Human Genome Project. Now, besides bioresearch applications, Perki…
Genomic Health, TriPath Imaging, Bio-Reference Labs, Canadian Patient Registry
PREDICTIVE TESTING FOR RECURRENT BREAST CANCER LABORATORY TESTS DESIGNED to predict the recurrence of breast cancer are picking up momentum. First to market was Genomic Health Inc.’s Oncotype DX™ breast cancer test. Now TriPath Imaging, Inc. is reporting…
January 16, 2006 “Intelligence: Late Breaking Lab News”
In recent months, the buzz around the lab industry in Southern California has been that Healthline Clinical Laboratories, Inc. is up for sale. THE DARK REPORT believes news of a sales agreement is imminent. The new buyer is likely to be a pair of looking-for-work lab executives in th…
Pathologists: Will CDHP-insured Patients Pay You?
FOR THOSE AMONG YOU WHO THINK STRATEGICALLY, our White Paper is sure to be a revelation. It is a sophisticated and detailed overview of the role Consumer-Directed Health Plans (CDHPs) will play in the upcoming revolution within the American healthcare system. Today I’d like to address one specific…
Helping Labs Get Ahead Of the CDHP Tsunami
THIS IS THE THIRD WHITE PAPER published by THE DARK REPORT in the past 10 years. We think you will find it the single most important intelligence briefing we’ve produced. That’s because of two reasons. First, the American healthcare system is in the earliest stages of total revolution. Like ever…
Consumer-Directed Health Plans To Be Healthcare’s Next Wave
“There is an opportunity for laboratories to put strategies in place to benefit from the changes triggered by wider use of CDHPs.” —Paul Mango CEO SUMMARY: It is widely known that growing numbers of employers are turning to consumer-directed…
Internet as Threat and Opportunity for Labs
IT’S BEEN A WHILE SINCE THIS CRUSTY CURMUDGEON WEIGHED IN ON technology changes with the potential to reshape laboratory services as we know them today. Howe…
Picking Top Ten Stories Of 2005 for Lab Industry
CEO SUMMARY: THE DARK REPORT offers its pic…
Middleware Provides Opportunity For Labs to Gain New Functions
“Even as more laboratories begin to use middleware, the number of functions and uses for middleware continues to increase —Gregory R Vail, CEO, Data Innovations, Inc. CEO SUMMARY: Middleware is attracting attention throughout the laboratory ind…
CURRENT ISSUE
Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.